Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-7 of 7
Keywords: Ipratropium
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Journal:
Respiration
Respiration (1986) 50 (Suppl. 2): 276–279.
Published Online: 16 January 2009
... mg ipratropium bromide (IB)]; (2) [0.2 mg salbutamol (S)], and (3) [0.5 mg terbutaline (T)]. There were no secondary effects resulting from any treatment. Maximum effectiveness appeared on FEV 1 at 60 min with F + IB, and at 45 min with S and T. On V max25 , it was produced after 30 min with F + IB...
Journal Articles
Journal:
Respiration
Respiration (1986) 50 (Suppl. 2): 313–317.
Published Online: 16 January 2009
...Juan Antonio Mazzei; Jorge Torres A blind randomized cross-over comparative study of salbutamol and the combination fenoterol/ipratropium was carried out in 20 patients with mild to moderate bronchial asthma; clinical and functional serial parameters were evaluated. The combination was more...
Journal Articles
Journal:
Respiration
Respiration (1986) 50 (Suppl. 2): 270–273.
Published Online: 16 January 2009
...L. Frølund; F. Madsen; U.G. Svendsen; B. Weeke Twenty-one stable asthmatic patients were randomly allocated to be treated with either Duovent ® (ipratropium bromide 40 µg and fenoterol 100 µ g) and Berodual ® (ipratropium bromide 20 µg and fenoterol 50 µg) in a cross-over double-blind design over...
Journal Articles
Journal:
Respiration
Respiration (1986) 50 (Suppl. 2): 232–235.
Published Online: 16 January 2009
...R. Barnabè; M. Pirrelli; M. Rossi Fourteen out-patients with chronic bronchitis (n = 5) or chronic bronchial asthma (n = 9) entered a trial devised to evaluate the effect of the combined inhalation by pressurized aerosol of fenoterol 200 µ g + ipratropium bromide 80 µ g three times daily in a 12...
Journal Articles
Journal:
Respiration
Respiration (1984) 46 (4): 370–378.
Published Online: 15 January 2009
... hyperreactivity Carbachol Fenoterol Ipratropium SCH 1000 © 1984 S. Karger AG, Basel 1984 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic...
Journal Articles
Journal:
Respiration
Respiration (1981) 42 (3): 188–192.
Published Online: 14 January 2009
...J. Lulling; J.P. Delwiche; J. Prignot The bronchodilating effects of a metered aerosol dose of 40 μg ipratropium bromide and of 200 μg oxitropium bromide are similar 15 min after administration. The bronchodilating activity of ipratropium bromide appears earlier (i.e. 75–90 s after administration...
Journal Articles
Nicholas Gross, Donald Tashkin, Randall Miller, Joseph Oren, William Coleman, Steven Linberg, D Dey Combination Solution Study Group
Journal:
Respiration
Respiration (1998) 65 (5): 354–362.
Published Online: 30 October 1998
... of this double-blind, randomized, positive-control trial was to determine the effectiveness of an albuterol-ipratropium solution aerosol combination (Dey combination solution, Dey LP, Napa, Calif., USA) compared with solution aerosols of both component medications administered alone in patients with COPD...